Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Impact of tea drinking upon tuberculosis: a neglected issue

Authors: Mengshi Chen, Jing Deng, Wufei Li, Dan Lin, Congxu Su, Mian Wang, Xun Li, Benjamin Kwaku Abuaku, Hongzhuan Tan, Shi Wu Wen

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Tuberculosis (TB) is a global public health issue posing serious harm to the human health. Many studies have suggested that smoking and excessive alcohol consumption are risk factors for TB. Laboratory evidence suggests that EGCG in tea leaves can arrest the growth of tubercle bacillus. Can drinking tea lead to decreased susceptibility of TB in humans?

Methods

A total of 574 TB patients and 582 healthy controls were recruited to participate in this case–control study. Self-designed questionnaire was used to collect data. Unconditioned logistic regression analysis was conducted to identify the associations between tea drinking and TB.

Results

Tea drinking has a negative association with TB, with OR = 0.583(0.423, 0.804) and P < 0.05. Drinking black tea, oolong and green tea are all negative association with TB, with OR being 0.683(0.517, 0.902), 0.674(0.508, 0.894) and 0.534(0.349, 0.817) respectively and P < 0.05. Trend χ2 test indicated a decreasing risk for TB with increased tea consumption, with P < 0.05.

Conclusion

There is a significance negative association between tea drinking and TB. Promoting the consumption of tea as the daily drink among populations, particularly those with high TB risk, may reduce the incidence of TB in the populations.
Literature
1.
WHO. Global tuberculosis report 2013. Geneva: WHO; 2013.
2.
Survey TGGotFNTE, Survey TOotFNTE. The Fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34(8):485–508.
3.
Graham HN. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine. 1992;21(3):334–50.CrossRefPubMed
4.
Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, Mangeshkar P, et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. European Journal of Pharmacology. 2008;579(1–3):411–7.CrossRefPubMed
5.
Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother. 2008;62(3):189–96.CrossRefPubMed
6.
de Mejia EG, Ramirez-Mares MV, Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior. Brain, Behavior, and Immunity. 2009;23(6):721–31.CrossRefPubMed
7.
Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol, (−)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. The Journal of Nutrition. 2008;138(9):1677–83.PubMedPubMedCentral
8.
Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obesity (2005). 2005;29(6):615–23.CrossRef
9.
Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Annals of nutrition & metabolism. 2005;49(1):54–63.CrossRef
10.
Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, et al. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundamental & Clinical Pharmacology. 2008;22(3):275–84.CrossRef
11.
Lou FQ, Zhang MF, Zhang XG, Liu JM, Yuan WL. A study on tea-pigment in prevention of atherosclerosis. Chinese Medical Journal. 1989;102(8):579–83.PubMed
12.
Jochmann N, Baumann G, Stangl V. Green tea and cardiovascular disease: from molecular targets towards human health. Current Opinion in Clinical Nutrition and Metabolic Care. 2008;11(6):758–65.CrossRefPubMed
13.
Kim HR, Rajaiah R, Wu QL, Satpute SR, Tan MT, Simon JE, et al. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. The Journal of Nutrition. 2008;138(11):2111–6.CrossRefPubMedPubMedCentral
14.
Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. The American Journal of Pathology. 2012;180(1):221–34.CrossRefPubMed
15.
Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(38):14692–7.CrossRefPubMedPubMedCentral
16.
Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. Journal of Immunology. 2004;173(9):5794–800.CrossRef
17.
Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(8):4524–9.CrossRefPubMedPubMedCentral
18.
Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2003;17(8):952–4.
19.
Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Research. 2005;65(22):10623–31.CrossRefPubMed
20.
Yang CS, Liao J, Yang GY, Lu G. Inhibition of lung tumorigenesis by tea. Experimental Lung Research. 2005;31(1):135–44.CrossRefPubMed
21.
Kundu JK, Surh YJ. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. Annals of the New York Academy of Sciences. 2007;1095:504–12.CrossRefPubMed
22.
Adhami VM, Siddiqui IA, Sarfaraz S, Khwaja SI, Hafeez BB, Ahmad N, et al. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2009;15(6):1947–53.CrossRef
23.
Sharma SK, Kumar G, Kapoor M, Surolia A. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications. 2008;368(1):12–7.CrossRefPubMed
24.
Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. The International Journal of Biochemistry & Cell Biology. 2006;38(4):600–9.CrossRef
25.
WHO: Treatment of tuberculosis: guidelines - 4th ed. Geneva, WHO 2010.
26.
Chen M, Kwaku AB, Chen Y, Huang X, Tan H, Wen SW. Gender and regional disparities of tuberculosis in Hunan, China. Int Journal for Equity in Health. 2014;13:32.CrossRef
27.
Lakshmi PV, Virdi NK, Thakur JS, Smith KR, Bates MN, Kumar R. Biomass fuel and risk of tuberculosis: a case–control study from Northern India. Journal of Epidemiology and Community Health. 2012;66(5):457–61.CrossRefPubMed
28.
Sumpter C, Chandramohan D. Systematic review and meta-analysis of the associations between indoor air pollution and tuberculosis. Tropical Medicine & International Health : TM & IH. 2013;18(1):101–8.CrossRef
29.
Garcia-Sancho MC, Garcia-Garcia L, Baez-Saldana R, Ponce-De-Leon A, Sifuentes-Osornio J, Bobadilla-Del-valle M, et al. Indoor pollution as an occupational risk factor for tuberculosis among women: a population-based, gender oriented, case–control study in Southern Mexico. Rev Invest Clin; Organo del Hospital de Enfermedades de la Nutricion. 2009;61(5):392–8.
30.
Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested case–control study. Thorax. 2009;64(8):705–8.CrossRefPubMed
31.
Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2014;58(4):470–80.CrossRef
32.
Principi N, Esposito S. The present and future of tuberculosis vaccinations. Tuberculosis. 2015;95(1):6–13.CrossRefPubMed
33.
Pae M, Wu D. Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications. Food & Function. 2013;4(9):1287–303.CrossRef
34.
Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. Journal of Biological Chemistry. 2004;279(30):30994–1001.CrossRefPubMed
35.
Sharma SK, Parasuraman P, Kumar G, Surolia N, Surolia A. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). Journal of Medicinal Chemistry. 2007;50(4):765–75.CrossRefPubMed
Metadata
Title
Impact of tea drinking upon tuberculosis: a neglected issue
Authors
Mengshi Chen
Jing Deng
Wufei Li
Dan Lin
Congxu Su
Mian Wang
Xun Li
Benjamin Kwaku Abuaku
Hongzhuan Tan
Shi Wu Wen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1855-6

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Research article

Use of mobile phone consultations during home visits by Community Health Workers for maternal and newborn care: community experiences from Masindi and Kiryandongo districts, Uganda

Research article

Using prediction markets of market scoring rule to forecast infectious diseases: a case study in Taiwan

Research article

Exploring participant appreciation of group-based principles for action in community-based physical activity programs for socially vulnerable groups in the Netherlands

Research article

The influence of family history of Hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults

Research article

Household food insecurity, diet, and weight status in a disadvantaged district of Ho Chi Minh City, Vietnam: a cross-sectional study

Research article

Diet, physical activity and socio-economic disparities of obesity in Lebanese adults: findings from a national study